Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 127

1.

Relevance of tumor-infiltrating lymphocytes in breast cancer.

Dushyanthen S, Beavis PA, Savas P, Teo ZL, Zhou C, Mansour M, Darcy PK, Loi S.

BMC Med. 2015 Aug 24;13(1):202. doi: 10.1186/s12916-015-0431-3.

2.

Estimating body composition from skinfold thicknesses and bioelectrical impedance analysis in cystic fibrosis patients.

Alicandro G, Battezzati A, Bianchi ML, Loi S, Speziali C, Bisogno A, Colombo C.

J Cyst Fibros. 2015 Aug 14. pii: S1569-1993(15)00173-3. doi: 10.1016/j.jcf.2015.07.011. [Epub ahead of print]

PMID:
26282837
3.

Molecular segmentation of luminal breast: Reality in 2015?

Teo ZL, Loi S.

Breast. 2015 Aug 5. pii: S0960-9776(15)00148-4. doi: 10.1016/j.breast.2015.07.010. [Epub ahead of print]

PMID:
26255199
4.

Constitutive phosphorylated STAT3-associated gene signature is predictive for trastuzumab resistance in primary HER2-positive breast cancer.

Sonnenblick A, Brohée S, Fumagalli D, Vincent D, Venet D, Ignatiadis M, Salgado R, Van den Eynden G, Rothé F, Desmedt C, Neven P, Loibl S, Denkert C, Joensuu H, Loi S, Sirtaine N, Kellokumpu-Lehtinen PL, Piccart M, Sotiriou C.

BMC Med. 2015 Aug 3;13(1):177. doi: 10.1186/s12916-015-0416-2.

5.

Precision medicine for metastatic breast cancer-limitations and solutions.

Arnedos M, Vicier C, Loi S, Lefebvre C, Michiels S, Bonnefoi H, Andre F.

Nat Rev Clin Oncol. 2015 Jul 21. doi: 10.1038/nrclinonc.2015.123. [Epub ahead of print] Review.

PMID:
26196250
6.

Tumor-Infiltrating Lymphocytes and Associations With Pathological Complete Response and Event-Free Survival in HER2-Positive Early-Stage Breast Cancer Treated With Lapatinib and Trastuzumab: A Secondary Analysis of the NeoALTTO Trial.

Salgado R, Denkert C, Campbell C, Savas P, Nucifero P, Aura C, de Azambuja E, Eidtmann H, Ellis CE, Baselga J, Piccart-Gebhart MJ, Michiels S, Bradbury I, Sotiriou C, Loi S.

JAMA Oncol. 2015 Jul 1;1(4):448-54. doi: 10.1001/jamaoncol.2015.0830.

PMID:
26181252
7.

The adverse mental health of carers: Does the patient diagnosis play a role?

Loi SM, Dow B, Moore K, Hill K, Russell M, Cyarto E, Malta S, Ames D, Lautenschlager NT.

Maturitas. 2015 Sep;82(1):134-8. doi: 10.1016/j.maturitas.2015.06.034. Epub 2015 Jun 23.

PMID:
26163076
8.

Factors associated with depression in older carers.

Loi SM, Dow B, Moore K, Hill K, Russell M, Cyarto E, Malta S, Ames D, Lautenschlager N.

Int J Geriatr Psychiatry. 2015 Jul 7. doi: 10.1002/gps.4323. [Epub ahead of print]

PMID:
26153792
9.

Attitudes to aging in older carers - do they have a role in their well-being?

Loi SM, Dow B, Moore K, Hill K, Russell M, Cyarto E, Malta S, Ames D, Lautenschlager NT.

Int Psychogeriatr. 2015 Jun 15:1-9. [Epub ahead of print]

PMID:
26073317
10.

A network meta-analysis of everolimus plus exemestane versus chemotherapy in the first- and second-line treatment of estrogen receptor-positive metastatic breast cancer.

Generali D, Venturini S, Rognoni C, Ciani O, Pusztai L, Loi S, Jerusalem G, Bottini A, Tarricone R.

Breast Cancer Res Treat. 2015 Jul;152(1):95-117. doi: 10.1007/s10549-015-3453-9. Epub 2015 Jun 5.

PMID:
26044370
11.

Palbociclib in Hormone-Receptor-Positive Advanced Breast Cancer.

Turner NC, Ro J, André F, Loi S, Verma S, Iwata H, Harbeck N, Loibl S, Huang Bartlett C, Zhang K, Giorgetti C, Randolph S, Koehler M, Cristofanilli M.

N Engl J Med. 2015 Jul 16;373(3):209-19. doi: 10.1056/NEJMoa1505270. Epub 2015 Jun 1.

PMID:
26030518
12.

Immune targeting in breast cancer: in whom and with what?

Loi S.

Oncology (Williston Park). 2015 May;29(5):386-7. No abstract available.

13.

Aged persons mental health service in rural Victoria.

Loi SM, Bradshaw L, Gilbert V.

Aust J Rural Health. 2015 May 6. doi: 10.1111/ajr.12179. [Epub ahead of print] No abstract available.

PMID:
25946640
14.

Consensus guidelines for the detection of immunogenic cell death.

Kepp O, Senovilla L, Vitale I, Vacchelli E, Adjemian S, Agostinis P, Apetoh L, Aranda F, Barnaba V, Bloy N, Bracci L, Breckpot K, Brough D, Buqué A, Castro MG, Cirone M, Colombo MI, Cremer I, Demaria S, Dini L, Eliopoulos AG, Faggioni A, Formenti SC, Fučíková J, Gabriele L, Gaipl US, Galon J, Garg A, Ghiringhelli F, Giese NA, Guo ZS, Hemminki A, Herrmann M, Hodge JW, Holdenrieder S, Honeychurch J, Hu HM, Huang X, Illidge TM, Kono K, Korbelik M, Krysko DV, Loi S, Lowenstein PR, Lugli E, Ma Y, Madeo F, Manfredi AA, Martins I, Mavilio D, Menger L, Merendino N, Michaud M, Mignot G, Mossman KL, Multhoff G, Oehler R, Palombo F, Panaretakis T, Pol J, Proietti E, Ricci JE, Riganti C, Rovere-Querini P, Rubartelli A, Sistigu A, Smyth MJ, Sonnemann J, Spisek R, Stagg J, Sukkurwala AQ, Tartour E, Thorburn A, Thorne SH, Vandenabeele P, Velotti F, Workenhe ST, Yang H, Zong WX, Zitvogel L, Kroemer G, Galluzzi L.

Oncoimmunology. 2014 Dec 13;3(9):e955691. eCollection 2014 Oct. Review.

PMID:
25941621
15.

Minimising psychotropic use for behavioural disturbance in residential aged care.

Loi SM, Westphal A, Ames D, Lautenschlager NT.

Aust Fam Physician. 2015 Apr;44(4):180-4.

16.

Uncovering the genomic heterogeneity of multifocal breast cancer.

Desmedt C, Fumagalli D, Pietri E, Zoppoli G, Brown D, Nik-Zainal S, Gundem G, Rothé F, Majjaj S, Garuti A, Carminati E, Loi S, Van Brussel T, Boeckx B, Maetens M, Mudie L, Vincent D, Kheddoumi N, Serra L, Massa I, Ballestrero A, Amadori D, Salgado R, de Wind A, Lambrechts D, Piccart M, Larsimont D, Campbell PJ, Sotiriou C.

J Pathol. 2015 Aug;236(4):457-66. doi: 10.1002/path.4540. Epub 2015 May 7.

PMID:
25850943
17.

RANK-ligand (RANKL) expression in young breast cancer patients and during pregnancy.

Azim HA Jr, Peccatori FA, Brohée S, Branstetter D, Loi S, Viale G, Piccart M, Dougall WC, Pruneri G, Sotiriou C.

Breast Cancer Res. 2015 Feb 21;17:24. doi: 10.1186/s13058-015-0538-7.

18.

Reply to A. Ocaña et al and P.G. Tsoutsou et al.

Loi S.

J Clin Oncol. 2015 Apr 10;33(11):1299-300. doi: 10.1200/JCO.2014.59.9423. Epub 2015 Mar 9. No abstract available.

PMID:
25753442
19.

Tumour infiltrating lymphocytes (TILs) in breast cancer during pregnancy.

Azim HA Jr, Vingiani A, Peccatori F, Viale G, Loi S, Pruneri G.

Breast. 2015 Jun;24(3):290-3. doi: 10.1016/j.breast.2015.01.009. Epub 2015 Feb 18.

PMID:
25702955
20.

Adenosine Receptor 2A Blockade Increases the Efficacy of Anti-PD-1 through Enhanced Antitumor T-cell Responses.

Beavis PA, Milenkovski N, Henderson MA, John LB, Allard B, Loi S, Kershaw MH, Stagg J, Darcy PK.

Cancer Immunol Res. 2015 May;3(5):506-17. doi: 10.1158/2326-6066.CIR-14-0211. Epub 2015 Feb 11.

PMID:
25672397
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk